Clinical Trial Update: Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

Open-label extension study investigating the effects of pomegranate extract on rising PSA after primary therapy in men with prostate cancer (Phase 2; status unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pomegranate Extract

Snippet

Sponsor: Roll International Corporation | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN